Janux Therapeutics, Inc. (JANX)

USD 28.54

(6.22%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue 8.08 Million 8.61 Million 3.63 Million - -
Cost of Revenue 54.92 Million 841 Thousand 113 Thousand 13 Thousand 6000.00
Gross Profit -46.83 Million 7.77 Million 3.52 Million -13 Thousand -6000.00
Operating Expenses 81.06 Million 75.7 Million 36.56 Million 4.84 Million 3.77 Million
Selling, General and Administrative Expenses 26.14 Million 22.26 Million 10.32 Million 1.8 Million 772 Thousand
Research and Development Expenses 54.92 Million 53.44 Million 26.23 Million 3.04 Million 2.99 Million
Other Expenses - 4.03 Million 257 Thousand -1.73 Million -
Cost and Expenses 81.06 Million 75.7 Million 36.56 Million 4.84 Million 3.77 Million
Operating Income -72.97 Million -67.09 Million -32.92 Million -4.84 Million -3.77 Million
Interest Expense - 4.03 Million - 206 Thousand 233 Thousand
Income Tax Expense - -8.9 Million -113 Thousand -1.52 Million 233 Thousand
Earnings before Tax -58.29 Million -63.05 Million -32.67 Million -6.78 Million -4 Million
Net Income -58.29 Million -54.15 Million -32.55 Million -5.25 Million -4.23 Million
Earnings Per Share Basic -1.32 -1.31 -0.79 -0.13 -0.10
Earnings Per Share Diluted -1.32 -1.31 -0.79 -0.13 -0.10
Weighted Average Shares Outstanding 44.01 Million 41.46 Million 41.24 Million 41.61 Million 41.61 Million
Weighted Average Shares Outstanding (Diluted) 44.01 Million 41.46 Million 41.24 Million 41.61 Million 41.61 Million
Gross Margin -5.79 0.90 0.97 - -
EBIT Margin -8.79 -7.79 -9.05 - -
Profit Margin -7.21 -6.29 -8.95 - -
EBITDA -71.02 Million -66.25 Million -32.81 Million -4.83 Million -3.76 Million
Earnings Before Tax Margin -9.03 -7.79 -9.05 - -

Income Statement Charts